How to Choose a Regulatory Translation Partner for LATAM Submissions

Most sponsors treat regulatory translation as a procurement line item. Find a vendor, negotiate a per-word rate, send the documents, get them back. The assumption is that translation is translation.

In Latin America, that assumption costs sponsors between 60 and 120 days per submission.

The reason is straightforward: LATAM regulatory translation is not a language problem. It is a regulatory knowledge problem delivered through language. The translator who handles your dossier needs to know what COFEPRIS expects in a device description, what ANVISA requires in a sworn translation, what INVIMA flags in an IFU, and how ANMAT interprets a certificate of free sale differently from DIGEMID.

No general translation agency teaches this. No freelancer picks it up from terminology databases. This knowledge comes from reading thousands of RFIs issued by specific regulators and understanding why each one was triggered.

A qualified regulatory translation partner does not just convert text from English to Spanish or Portuguese. They perform three functions that generic vendors cannot:

1. Regulator-specific terminology mapping. Each LATAM authority has preferred terms for device classifications, clinical endpoints, and safety reporting language. COFEPRIS uses terminology that differs from INVIMA, which differs from ANVISA. A regulatory translation partner maintains terminology databases organized by regulator, not by language pair.

2. Document-type routing. Different documents require different translation types in different countries. Brazil requires sworn translations for most submission documents. Mexico accepts certified translations for technical files but may require sworn translations for legal certificates. Argentina has its own matrix. A regulatory partner knows which type each document needs before the project starts, not after the regulator rejects it.

3. Pre-submission QC against known rejection patterns. The most valuable thing a regulatory translation partner does is catch the errors that regulators catch, before submission. This means reviewing every translated document against the specific formatting, terminology, and structural expectations of the target authority.

Tier 1: General freelancers and agencies ($0.05 to $0.14/word). These providers handle the mechanical conversion. Grammar is correct. Terminology is sourced from general medical dictionaries. They have no regulatory context and no visibility into what specific authorities actually reject.

Tier 2: Specialist regulatory translation firms ($0.19 to $0.38/word). These firms employ translators with direct regulatory submission experience. They maintain regulator-specific terminology databases, know the difference between sworn and certified requirements by country, and review documents against known RFI patterns. Amavita Sciences™ operates in this tier.

Tier 3: Global language service providers ($0.28 to $0.45/word). Large firms with infrastructure across dozens of languages. The quality can be strong, but the LATAM regulatory depth varies by which translator is assigned to your project. The premium price pays for project management and global reach, not necessarily for jurisdiction-specific expertise.

1. Can you show me an RFI that was triggered by a translation error you would have caught? If they cannot point to a specific example with a specific regulator, they do not have the pattern recognition you need.

2. Do you maintain separate terminology databases by regulator? A single Spanish glossary is not enough. COFEPRIS Spanish and INVIMA Spanish are operationally different.

3. How do you determine whether a document needs sworn or certified translation? The answer should reference specific country requirements, not a general policy.

4. What is your QC process before delivery? Look for regulator-specific review steps, not just proofreading and back-translation.

5. What is your first-pass acceptance rate with LATAM regulators? This is the only metric that matters. If they do not track it, they do not have the feedback loop that drives improvement.

A regulatory submission in LATAM touches between 6 and 12 authorities, each with its own language, terminology, and formatting expectations. One translation error in one document for one country can add 60 to 120 days to your timeline.

Multiply that across a multi-country submission and the cost of choosing the wrong translation partner is not the per-word rate difference. It is the months of delay, the site activation holdups, and the enrollment windows that close while you are responding to RFIs that should never have been issued.

The translation partner you choose is not a vendor decision. It is a regulatory strategy decision.

Amavita Sciences™ is a specialist regulatory translation firm serving MedTech and biopharma sponsors across 12 LATAM markets. We maintain regulator-specific terminology databases for ANVISA, INVIMA, COFEPRIS, ANMAT, DIGEMID, ISP, ARCSA, DNM, and SRS, and we guarantee first-pass acceptance on every deliverable.